SITC Cancer Immunotherapy CONNECT

sitc_log_color.png

SITC Cancer Immunotherapy Guidelines – Cutaneous Melanoma Webinar on July 30
Join SITC experts to discuss immunotherapy treatment standards for melanoma on the recently updated clinical guidelines manuscript in a free webinar at 6 p.m. ET on July 30.

Learn More and Register

cig-big.png

Join SITC or Sign In to Vote in the SITC Election*

Polls Close Thursday, June 28

Learn more

*Available to SITC regular and emeritus members only. Student members who recently completed training may apply for regular membership by contacting info@sitcancer.org.



sitc_log_color.png

June is Cancer Immunotherapy Month™

Learn about immunology principles in immunotherapy of cancer at the SITC Primer on Tumor Immunology and Cancer Immunotherapy™, part of our Pre-Conference Programs, on Nov. 8, 2018.

Learn More

sitc-connect-ed-cmyk_FINAL.png

Understand Cancer Immunotherapy With This
Free Online Activity

The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.

Register for the online ACTIVITY


 

Register Now & Submit Your Research to SITC 2018

SITC 2018 registration is now open to the public. Also, submit an abstract to the 33rd Annual Meeting or presentation application to the Immune Escape program!

Check Out SITC 2018

sitc_log_white.png

Learn the Value of 
SITC MEMBERSHIP!

member-ribbon-v4.pngSee members discuss the benefits of a SITC membership in this new video.

Watch The Video

SITC-blk.png

The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • At the outset it would seem that a deactivation of immune system stands be antithetical to the very purpose of immunotherapy-based approach whereby a healthy uncompromising immune systems is need as a platform for any effective CART-1 PD-CART  or PD -PDl1 ...

  • At the outset it would seem that a deactivation of immune system stands be antithetical to the very purpose of immunotherapy-based approach whereby a healthy uncompromising immune systems is need as a platform for any effective CART-1 PD-CART or PD ...

  • Hello Dr.  Ramakrishna, The answer is not know yet.  There are many trials (listed below) aimed at this indication. None that I know of yet are combining targeted therapy (FLT3 inhibitor) with immune therapy, but I am sure there will be some coming ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More